New study exposes teenagers' easy access to cigarettes in China
The Asia Health Policy Program (AHPP) at Stanford’s Shorenstein Asia-Pacific Research Center (Shorenstein APARC) looks forward to welcoming its incoming 2012–13 research fellows from Mongolian Medical University, the University of Hawai’i, and Harvard. AHPP’s new fellows specialize in research topics including cervical cancer prevention, migrant remittances, and the political economy of support for the elderly.
Developing Asia Health Policy Fellows
Baigalimaa Gendendarjaa will be joining AHPP from the Mongolian National Cancer Center. Her research includes a comparative study of how knowledge of cervical cancer risk factors has influenced behavior changes in Mongolia before and after the introduction of the National Cervical Cancer Program. She holds a master’s degree in medicine from Mongolian Medical University.
Asia Health Policy Postdoctoral Fellow
Yuki Takagi earned her PhD in government from Harvard University and is completing a postdoctoral fellowship at Princeton. Her dissertation research focuses on the political economy of support for the elderly and intergenerational family transfers, such as nursing and childcare, focusing on Japan. Takagi holds bachelor of economics and master of law degrees from the University of Tokyo.
Throughout the academic year the AHPP fellows will present seminars, take part in individual and collaborative research projects, and participate in campus events.
In spring 2009, China’s leadership announced ambitious national health reforms. Have the five stated goals of the first three years of reform been met? What policies will China pursue in the next phase? As a prominent advisor to China's State Council Health Reform Office, Liu will discuss progress and prospects for reforms—especially the role of the private sector within the health system—within the context of China’s 2012 leadership transition.
Gordon Liu is a professor of economics at Peking University's (PKU) Guanghua School of Management, and director of PKU's China Center for Health Economic Research. Previously, he served as a tenured associate professor at the University of North Carolina at Chapel Hill (2000–2006), and as an assistant professor at the University of Southern California (1994–2000).
Liu's primary research interests include health and development economics, health policy and reform, and pharmaceutical economics. His current research is funded by the State Council Health Reform Office, the National Science Foundation, UNICEF, and the China Medical Board.
Liu currently serves on the State Council Health Reform Advisory Commission, and the Expert Panel for the State Ministry of Human Resource and Social Security. He serves as co-editor for the journal Value in Health, and as editor-in-chief for China Journal of Pharmaceutical Economics. He sits on the editorial boards for the European Health Economic Review, Global Handbook for Health Economics, and Chinese Journal of Health Economics.
He received his PhD in Economics from the City University of New York Graduate School while working as a graduate research fellow at the National Bureau of Economic Research under the supervision of Michael Grossman (1986–1991). He obtained post-doctoral training at Harvard University with William Hsiao (1992–1993). Liu has served as the president for the Chinese Economists Society, and chair for the Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research.
Philippines Conference Room
China’s demographic landscape is rapidly changing, and the government has responded by launching ambitious social and health service reforms to meet the changing needs of the country’s 1.3 billion people. This week, officials approved a five-year plan to develop a comprehensive nationwide social security network.
Karen Eggleston, the Asia Health Policy Program (AHPP) director and a Stanford Health Policy fellow, discusses the success of China’s health care reforms—including its recently established universal health care system—and the long road still ahead.
Why is the overall health and wellbeing of China’s population important globally?
There are many reasons why the health of China’s citizens matters within a larger global context. On the most basic level, China represents almost 20 percent of humanity. But it is also a major player in the world economy and it depends on having a healthy workforce, especially now that its population is aging more. The government’s ability to meet the needs of its underserved citizens contributes to a more productive and stable China, and works towards closing the huge gaps we see in human wellbeing across the world.
China also potentially offers a model for other developing countries, such as India, that may want to figure out how to make universal health coverage work at a tenth of the income of most of the countries that have put it into place before.
What are some of the biggest changes in China’s health care system since 1949?
One of the most significant changes is that China has achieved very basic universal health insurance coverage in a relatively short period of time.
Throughout the Mao period (1949–1978) there was a health care system linked to the centrally planned economy, which provided a basic level of coverage via government providers with a lot of regional variation. When economic reform came in 1980, large parts of the system—particularly financing for insurance—collapsed. The majority of China’s citizens were uninsured during the past few decades of very rapid social and economic development.
China’s overall population is changing quite dramatically, which means it has different health care needs, such as treating chronic disease and caring for an increasingly elderly population. The central government is trying to establish a system of accessible primary care—a concept that China’s barefoot doctors helped to pioneer but that fell into disarray—and health services that fit these new needs.
How does China’s basic health care system work? Are there segments of the population still not receiving adequate coverage and care?
China has had a system where people can select their own doctors. Patients usually want to go to clinics attached to the highest-reputation hospitals, but of course, when you are not insured you almost always by default go to where you can afford the care. “It is difficult to see the doctor, and it is expensive” has been the lament of patients in China, so an explicit goal of the health care reforms has been to address this.
The term “universal coverage” has different definitions. China initially put in place a form of insurance that only covers 20 or 30 percent of medical costs for the previously uninsured population, especially in rural areas. Benefits have expanded, but remain limited. As with the previous system, disparities in coverage still exist across the population. China not only has a huge population with huge economic differences, but within that there is a large migrant worker population. It is a challenge to figure out how to cover these citizens and how to provide them with access to better care. The government is quite aware there are segments of the population not receiving equal coverage, and it continues to strive to resolve the issue.
What are the greatest innovations in China’s health care system in recent years?
One of the most remarkable things China has achieved is really its new health insurance system. Even if the current coverage is not particularly generous it is nearly universal, and mechanisms are put in place each year to provide more generous coverage. China is also working on strengthening its primary care and population health services, infusing a huge sum of government money into these efforts. It is the only developing country of its per-capita income that has achieved such results so far.
Interestingly, a lot of people assume China achieved its universal coverage by mandate, while in fact the central government did so by subsidizing the cost for local governments and individuals. This reduces the burden, for example, on poorer rural governments and residents, and is one innovative way China is trying to eliminate the disparity in access to care.
Eggleston has recently published a working paper on China’s health care reforms since the Mao era on the AHPP website, as well as an article in the Milken Institute Review.
Gordon Liu, a Chinese government advisor on health care and the executive director of Peking University’s Health Economics and Management Institute, spoke at Stanford on May 29 on the future of China’s health care system.
Along with the speeches and ceremonies to mark the opening of the Stanford Center at Peking University, Stanford scholars from the Freeman Spogli Institute for International Studies are showcasing their work examining China’s promises, challenges and increasingly important role in the world.
The Shorenstein Asia-Pacific Research Center held a two-day workshop examining China’s relationships with its neighbors. The event draws on work being done by Thomas Fingar, FSI’s Oksenberg-Rohlen Distinguished Fellow, who is leading a new initiative to explore the nuances and complexity of China’s foreign relations and domestic issues.
Scott Rozelle, co-director of the Rural Education Action Project, planned a conference on Thursday exploring the impacts of technology on China’s health and education systems. For years, Rozelle has studied how basic medicine and better meals improve children’s performance in school. He’s lately been evaluating the best and most affordable ways to use new technology in rural Chinese schools.
On March 26 and 27, the Asia Health Policy Program will focus on the challenges China’s growing tobacco-control movement faces against a multibillion-dollar government-run industry. Anthropologist Matthew Kohrman, a specialist on tobacco in China, will lead the workshop examining the connections woven over the past 60 years between marketing and cigarette gifting, production and consumer demand, government policy and economic profit, and the other forces behind China’s smoking culture.
“A postdoctoral program is crucial to the intellectual development of any strong academic institution. I am proud the Shorenstein Asia-Pacific Research Center will serve as a home next year for these four talented emerging Asia scholars. Not only will they benefit from taking part in our vibrant research and publishing activities, but they will also bring new expertise and perspectives to our Center.”
-Gi-Wook Shin, Director, Shorenstein APARC
In the coming academic year, the Shorenstein Postdoctoral Fellowship program will double in size.
The four incoming fellows represent the best of the next generation of contemporary Asia scholars. Their research ranges from civil society and authoritarian governance in China to ethnic conflict in South Asia, and Korean migration and identity to election politics in Japan.
During their time at the Shorenstein Asia-Pacific Research Center (Shorenstein APARC), the fellows will conduct their own research and writing, present their work at public seminars, and take part in the research and publishing activities of the Center. Postdoctoral fellows will also have the chance to exchange ideas with Shorenstein APARC experts and interact with the many distinguished visitors who visit each year from throughout the Asia-Pacific region.
In addition, the Asia Health Policy Program at Shorenstein APARC will welcome two postdoctoral fellows in the 2012–13 academic year: an Asia Health Policy Fellow and a Developing Asia Fellow.
Postdoctoral fellows are a vital part of the academic life of the Center, and their relationships with Shorenstein APARC will continue throughout their entire careers.
The Shorenstein Postdoctoral Fellowship Program is made possible through the generosity of Walter H. Shorenstein.
“This fellowship has changed the trajectory of my academic career. It has given me the intellectual space to be highly productive and the freedom to expand my understanding of world events in order to enhance my future teaching and research. Thanks in large part to the fellowship, I was able to obtain an appointment as an assistant professor in the Department of International Relations at Boston University.”
-Jeremy Menchik, 2011–12 Shorenstein Postdoctoral Fellow
2012–13 Shorenstein PostDoctoral Fellows
Diana Fu will be joining Shorenstein APARC from Oxford University’s Department of Politics and International Relations, and from the Massachusetts Institute of Technology where she recently served as a political science research fellow. Her research interests encompass state-society relations in authoritarian regimes, civil society, governance, and labor contention. She will be completing a series of journal articles about civil society and authoritarian governance in China. Fu holds an MPhil in international development from Oxford University where she studied as a Rhodes Scholar, and a BA in global studies and political science from the University of Minnesota.
Over the last hundred years, the cigarette has become a pillar of consumer life in China and many parts of the world. In 2010, the Chinese tobacco industry produced over two trillion cigarettes, generating over U.S. $90 billion in taxes and profits. Over 300 million Chinese citizens now use cigarettes every day, and tobacco kills 90 times more people each year than HIV/AIDS in China.
How has the cigarette become so integrated into the fabric of everyday life across the People’s Republic of China?
The importance of answering this question is unmistakable, but very little historical research and writing has examined China’s cigarette industry from the mid-20th century to the present. To get to the heart of this question, historians, health policy specialists, sociologists, anthropologists, business scholars, and other experts will meet Mar. 26 and 27 at the new Stanford Center at Peking University for a conference organized by the Asia Health Policy Program. They will examine connections intricately woven over the past 60 years between marketing and cigarette gifting, production and consumer demand, government policy and economic profit, and many other dimensions of China’s cigarette culture.
Stanford Center at Peking University
More than two decades have passed since the first case of HIV infection was detected in Cambodia in 1991. Cambodia is among the countries with the highest HIV prevalence in Asia and has been experiencing the most serious HIV/AIDS epidemic in the region. The epidemic is spread primarily through heterosexual transmission and revolves largely around the sex trade.
Since the beginning of the epidemic, the Royal Government of Cambodia has made a strong political commitment to the need for prevention of HIV transmission and care for people living with HIV/AIDS. It has received some technical and financial support from national and international agencies. Several prevention and intervention programs have been successfully implemented, and the WHO/UNAIDS recognized that the Cambodia’s HIV/AIDS epidemic appeared to have stabilized in 2002.
The estimated HIV prevalence in the general adult population declined to 0.5% in 2009, down from 1.2% in 2001. Among women visiting antenatal care clinics, the prevalence also declined from 2.1% in 1999 to 1.1% in 2006. There was also a gradual increase in the percentage of HIV-infected pregnant women who received antiretroviral therapy to reduce the risk of mother-to-child transmission, from 1.2% in 2003 to 11.2% in 2007, and finally to 32.3% in 2009.
Despite the decline of HIV prevalence in the general population, the prevalence remains high among high-risk groups such as commercial sex workers, men who have sex with men, and injection drug users. Furthermore, the so-called prevention-successful-country is also seeing the growing need for HIV/AIDS treatment and care.
This seminar will highlight the past and current features of Cambodia’s HIV/AIDS epidemic, lessons learned from prevention and care policies, and future challenges that Cambodia may face in the battles against HIV/AIDS.
Dr. Siyan Yi joins the Walter H. Shorenstein Asia-Pacific Research Center during the 2011–12 academic year from the National Center of Global Health and Medicine and the University of Tokyo, Japan, where he jointly served as a research fellow and lecturer. He has also served as an adjunct faculty member at Cambodia’s School of Public Health, the National Institute of Public Health, and the School of International Studies at the Royal University of Phnom Penh.
Daniel and Nancy Okimoto Conference Room
Dr. Siyan Yi joined the Walter H. Shorenstein Asia-Pacific Research Center (Shorenstein APARC) as a 2011-12 Developing Asia Health Policy Postdoctoral Fellow from the National Center of Global Health and Medicine and the University of Tokyo, Japan, where he jointly served as a research fellow and lecturer. He also served as an adjunct faculty member at Cambodia’s School of Public Health, the National Institute of Public Health, and the School of International Studies at the Royal University of Phnom Penh. He is currently an Associate Professor and UHS-SPH Integrated Research Programme Leader at NUS Saw Swee Hock School of Public Health (profile page here).
Yi’s research has centered largely on epidemiological methods. This has included, for example, work on surveys in Cambodia on adolescent risky sexual behaviors, substance abuse, and depression; a health promotion project in primary schools; sexual behaviors among people living with HIV/AIDS; and HIV risky behaviors among tuberculosis patients. Currently, he is involved in hospital- and community-based research projects in several developing countries as well as in Japan. He has published several papers in these research areas in international journals. His selected publications include:
Yi holds an MHSc (2007) and a PhD (2010) in international health sciences from the School of International Health at the University of Tokyo’s Graduate School of Medicine. He also earned an MD in general medicine from the University of Health Sciences, Cambodia (2001). Yi has won research awards, including: the Young Investigator Award from the Asia Pacific Academic Consortium for Public Health (2008), the Montreux Prize from the Swiss Association for Adolescent Health and the International Association for Adolescent Health (2009), and the Scientific Research Award from the University of Tokyo (2009).